Clinical Trials Browser

Hearing Loss, Sensorineural × Clear all

NCT06929468 2025-04-16

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

Not yet recruiting

Squamous Cell Carcinoma of Head and Neck, Ototoxicity, Deafness, Dizziness, Head and Neck Neoplasms, Hearing Loss, Sensorineural, Vestibular Diseases, Hearing Loss

NCT04241679 2024-04-25

ANTS

Phase NA Completed

Vestibulocochlear Nerve Diseases, Hearing Loss, Sensorineural, Neuroma, Acoustic, Retrocochlear Diseases, Skull Base Neoplasms, Vestibulocochlear Nerve Injuries

NCT04291209 2023-09-06

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Phase 1/2 Unknown

Deafness, Ear Diseases, Hearing Loss, Sensorineural, Hearing Loss

NCT02948790 2021-10-20

NeuriStim

Phase NA Completed

Hearing Loss, Sensorineural, Neuroma, Acoustic

NCT04270916 2020-03-25

Prevalence and Impact on QoL From Ototoxicity in Cancer Survivors

Hearing Loss, Sensorineural, Neoplasms, Tinnitus

NCT04281953 2020-03-25

Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors

Hearing Loss, Sensorineural, Neoplasms, Tinnitus